We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


PerkinElmer Cloud-Based Software Gain SOC 2 Certification for Research and Clinical Trial Data

PerkinElmer Cloud-Based Software Gain SOC 2 Certification for Research and Clinical Trial Data content piece image
Credit: Tobias Fischer/ Unsplash
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

PerkinElmer, Inc., announced that the PerkinElmer Signals™ Notebook and PerkinElmer Signals™ Medical Review SaaS solutions have been granted SOC 2 Level 1 Attestation for the American Institute of Certified Public Accountants (AICPA’s) Trust Service Principles of Security, Confidentiality and Availability.

The offerings receiving the SOC 2 certification focus on enhancing scientific workflows and enabling faster and easier analysis of drug candidate and clinical trial data.

PerkinElmer Signals Notebook is a research data management solution that allows scientists to capture, drag and drop, store, organize, share, find, and filter discovery information. It is fully integrated with PerkinElmer’s ChemDraw® software.

PerkinElmer Signals Medical Review software is purpose-built for medical monitors, enabling them to more efficiently detect safety signal issues during clinical trials. With the innovative combination of targeted workflow and industry-leading analytics driven by TIBCO Spotfire®, PerkinElmer Signals Medical Review software reduces the overall time to submission without compromising drug safety.

With the SOC 2 attestations, biotech and pharmaceutical companies have the added assurance that the PerkinElmer Signals solutions have been designed with intellectual property protection in mind— helping to guard against intrusion or theft by unauthorized users or other cyber security threats and providing expected availability levels as part of an organization’s overall IT infrastructure.

 “Security and compliance are must-haves for today’s biotech and pharmaceutical organizations as they look to increase innovation and collaboration by moving more R&D mission critical apps to the cloud,” said Kevin Willoe, VP and General Manager of Informatics, PerkinElmer. “By adding SOC 2 compliance to the PerkinElmer Signals Notebook and PerkinElmer Signals for Medical Review SaaS solutions, our customers can be assured these solutions are designed to support the security and availability excellence they need and demand.”

The PerkinElmer Signals solutions are part of PerkinElmer’s informatics software and services portfolio spanning across analytics, data connectivity and unification, electronic lab notebooks and data visualization for life science, manufacturing, food and beverage, chemical, agriculture and government markets.